NBP
NovaBridge Biosciences
1.30$
-1.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.4% | 85.7% | 78.3% | 84.4% | 85.4% | 89.0% | 89.4% | 83.1% | 83.5% | |
| 30.0% | 66.8% | 65.5% | 75.1% | 62.9% | 78.9% | 79.0% | 32.1% | 80.8% | |
| 56.0% | 77.6% | 67.3% | 75.6% | 76.4% | 84.7% | 84.5% | 81.5% | 80.9% | |
| 0.4% | 0.4% | 3.2% | 5.7% | 6.9% | 0.1% | 0.5% | 0.6% | 0.7% | |
| – | -9.1% | -3.2% | – | 0.5% | -2.0% | 7.8% | – | – | |
| 15.9% | 6.8% | 9.4% | 2.6% | 2.9% | 4.0% | 0.0% | – | – | |
| 14.5% | 6.3% | 8.6% | 1.9% | 2.1% | 2.9% | 4.5% | – | – | |
| 129.2% | 140.2% | 217.1% | 11.2% | 18.6% | 26.2% | 34.2% | 5.4% | 11.4% | |
| 19.0% | 14.6% | 33.9% | 9.1% | 11.1% | 16.2% | 15.8% | 4.0% | 10.3% | |
| 9.7% | 3.4% | 3.3% | 0.1% | 0.5% | 0.2% | 0.2% | 0.4% | 0.3% | |
| – | – | – | – | – | – | 2.3% | – | – | |
| 40.0% | -40.2% | 61.6% | 88.8% | 81.4% | 73.8% | 65.8% | 94.6% | 88.6% | |
| -34.9% | -42.7% | -143.5% | -31.9% | -77.7% | -166.1% | -342.6% | -604.7% | -511.4% | |
| 5.7% | 2.4% | 3.3% | 1.1% | 8.6% | 2.0% | 22.6% | 5.2% | 111.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.